Overall rank by patents
#25,622
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 6 technology areas, active 2017–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61J (CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES ).
The verdict
9155-0020 holds 10 US patents across 6 technology areas, rank #25,622 of 50,000 tracked assignees.
9155-0020 Quebec Inc. has been granted 10 US utility patents between 2017 and 2024, placing 9155-0020 Quebec Inc. at rank #25,622 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.3 claims per patent with primary concentration in A61J (CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES ). As a Foreign Corporation, 9155-0020 Quebec Inc. is one of the more focused assignees in the PatentsView dataset. By volume, 9155-0020 sits between 410 Medical, Inc. (10 patents, rank #25,618) and Aauxx Korea Co., Ltd (10 patents, rank #25,626) - the closest US assignees by grant volume. The composite Innovation Score of 31.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 5 in the 2015–2019 window, a +0% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. 9155-0020 Quebec Inc.'s 12.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark 9155-0020 Quebec Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
410 Medical, Inc.
10 patents
4DS MEMORY, LIMITED
10 patents
7Tunnels Inc.
10 patents
80 Percent Arms Inc.
10 patents
A LA CARTE MEDIA, INC.
10 patents
A&E Advanced Closure Systems, LLC
10 patents
A.R.E. ACCESSORIES LLC
10 patents
AAUXX KOREA CO., LTD
10 patents
9155-0020 Quebec Inc.
10 patents
What this shows 9155-0020 holds 10 patents at rank #25,622, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
9155-0020's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
31 Top 64% higher than 36% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 10.0% |
| 2018 | 1 | 10.0% |
| 2019 | 3 | 30.0% |
| 2020 | 1 | 10.0% |
| 2022 | 1 | 10.0% |
| 2023 | 1 | 10.0% |
| 2024 | 2 | 20.0% |
Top 6 of 6 technology areas
Overall rank by patents
#25,622
Across all tracked assignees
31.0 out of 100
How to use this portfolio
9155-0020's 10 grants land it in the top 64% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.